Lv41
550 积分 2025-04-23 加入
[Chinese expert consensus on clinical testing standards of PD-L1 expression for non-small cell lung cancer (2023 version)]
18天前
已完结
PD-1/PD-L1抑制剂疗效预测的生物标志物
19天前
已完结
Restriction of innate Tγδ17 cell plasticity by an AP-1 regulatory axis
2个月前
已完结
Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control
3个月前
已完结
BPS2025 - Engineering a tumor-sensitive prodrug T cell engager bispecific antibody for safer immunotherapy
3个月前
已完结
CLK2–SOX3 combination promotes choroidal neovascularization by SGLT1 inducing endothelial cell metabolic reprogramming
4个月前
已完结
A review of urinary HPV testing for cervical cancer management and HPV vaccine surveillance: rationale, strategies, and limitations
4个月前
已完结
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
4个月前
已完结
Novel strategies exploiting interleukin-12 in cancer immunotherapy
4个月前
已完结
Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis
5个月前
已完结
皖公网安备34019202002308
